Santa Monica, California Thursday, November 7, 2024, 10:00 Hrs [IST] ...

Australian inventor Lawrence Hargrave created history when he was lifted off the ground in a flying device he created in 1894. Now, 130 years later, he is remembered as a generous pioneer whose ...

This includes commercial company Innovative Cellular Therapeutics (ICT). The potential size of China's market means it cannot be ignored, and Kite Pharma and Fosun hope their tie-up will put ...

"The acquisition of Kite establishes Gilead as a leader in cellular therapy and provides a foundation from which to drive continued innovation for people with advanced cancers." He added ...

Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...

In the field of tumor immunotherapy, on September 13, 2024, Fosun Pharma announced it will acquire the 50% stake in Fosun Kite and will wholly own Fosun Kite (now renamed as "Fosun Kairos").

Fosun Pharma's innovative drug business mainly covers the core therapeutic areas of solid tumors, hematological tumors and immuno-inflammatory diseases, with emphasis on the enhancement of the core ...